疗效和安全性-话题@MedSci

#疗效和安全性#

431篇内容 | 2606人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1720895, encodeId=46931e208958d, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet：一种吻合性胃旁路手术与Roux-en-Y胃旁路手术治疗肥胖(YOMEGA)的疗效和安全性:一项多中心、随机、开放标签、非劣效性试验, objectType=article, longId=163537, objectId=89b716353e19, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89b716353e19, replyNumber=0, likeNumber=78, createdTime=2019-10-07, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89b716353e19, moduleTitle=Lancet：一种吻合性胃旁路手术与Roux-en-Y胃旁路手术治疗肥胖(YOMEGA)的疗效和安全性:一项多中心、随机、开放标签、非劣效性试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89b716353e19)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720889, encodeId=fc061e2088969, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=张会来教授：替雷利珠单抗治疗复发/难治性经典型霍奇金淋巴瘤疗效和安全性均优，应用前景可期, objectType=article, longId=156738, objectId=2f27156e3890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f27156e3890, replyNumber=0, likeNumber=78, createdTime=2019-02-23, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f27156e3890, moduleTitle=张会来教授：替雷利珠单抗治疗复发/难治性经典型霍奇金淋巴瘤疗效和安全性均优，应用前景可期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f27156e3890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720893, encodeId=e72e1e2089369, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Clin Med：Denosumab治疗骨质疏松症骨质疏松症的疗效和安全性, objectType=article, longId=160285, objectId=69931602858e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69931602858e, replyNumber=0, likeNumber=81, createdTime=2019-10-23, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69931602858e, moduleTitle=J Clin Med：Denosumab治疗骨质疏松症骨质疏松症的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69931602858e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720885, encodeId=71f21e20885f8, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：Venetoclax联合地西他滨或阿扎胞苷用于AML老年患者的疗效和安全性, objectType=article, longId=151985, objectId=bdd115198529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdd115198529, replyNumber=0, likeNumber=60, createdTime=2019-06-20, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdd115198529, moduleTitle=Blood：Venetoclax联合地西他滨或阿扎胞苷用于AML老年患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdd115198529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720880, encodeId=c6a11e208803b, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=坦度螺酮增效治疗高焦虑状态的抑郁症患者的疗效和安全性研究, objectType=article, longId=150200, objectId=2132150200f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2132150200f3, replyNumber=0, likeNumber=71, createdTime=2019-02-01, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2132150200f3, moduleTitle=坦度螺酮增效治疗高焦虑状态的抑郁症患者的疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2132150200f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720864, encodeId=a62c1e2086465, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet diabetes endo：磺脲类药物治疗KUNJ11突变导致的永久性新生儿糖尿病的长期疗效和安全性, objectType=article, longId=140058, objectId=a95c140058fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95c140058fb, replyNumber=0, likeNumber=74, createdTime=2018-08-18, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95c140058fb, moduleTitle=Lancet diabetes endo：磺脲类药物治疗KUNJ11突变导致的永久性新生儿糖尿病的长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95c140058fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720892, encodeId=41121e208925f, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Arthritis Rheumatol：ANCA相关性血管炎使用贝利木单抗和硫唑嘌呤维持缓解的疗效和安全性, objectType=article, longId=159224, objectId=96761592248b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96761592248b, replyNumber=0, likeNumber=96, createdTime=2020-01-12, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96761592248b, moduleTitle=Arthritis Rheumatol：ANCA相关性血管炎使用贝利木单抗和硫唑嘌呤维持缓解的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96761592248b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720888, encodeId=9d1f1e2088856, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Eur Heart J：阿司匹林对心血管事件一级预防的疗效和安全性分析, objectType=article, longId=156128, objectId=3d2f15612850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d2f15612850, replyNumber=0, likeNumber=85, createdTime=2019-07-11, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d2f15612850, moduleTitle=Eur Heart J：阿司匹林对心血管事件一级预防的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d2f15612850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720858, encodeId=19211e20858ce, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Diabetic Med：alirocumab在糖尿病前期患者和基线血糖正常患者中的疗效和安全性？, objectType=article, longId=133907, objectId=3fb713390ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb713390ef2, replyNumber=0, likeNumber=71, createdTime=2018-05-10, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb713390ef2, moduleTitle=Diabetic Med：alirocumab在糖尿病前期患者和基线血糖正常患者中的疗效和安全性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fb713390ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720859, encodeId=b8fd1e208594e, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性, objectType=article, longId=135698, objectId=b97d1356989d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b97d1356989d, replyNumber=0, likeNumber=73, createdTime=2019-02-14, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b97d1356989d, moduleTitle=Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97d1356989d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720870, encodeId=a4631e20870e7, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性, objectType=article, longId=146096, objectId=d7ec14609633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7ec14609633, replyNumber=0, likeNumber=103, createdTime=2019-04-20, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7ec14609633, moduleTitle=Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7ec14609633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720866, encodeId=ee511e2086694, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=CheckMate-078研究：首次印证免疫治疗在中国人群的疗效和安全性, objectType=article, longId=144370, objectId=4ef11443e01f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ef11443e01f, replyNumber=0, likeNumber=102, createdTime=2019-05-20, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ef11443e01f, moduleTitle=CheckMate-078研究：首次印证免疫治疗在中国人群的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ef11443e01f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720869, encodeId=06791e208690f, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Arthritis Rheumatol：缓释和速释非布索坦对痛风肾损害患者的疗效和安全性, objectType=article, longId=146017, objectId=8bcf14601ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bcf14601ef1, replyNumber=0, likeNumber=71, createdTime=2019-04-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bcf14601ef1, moduleTitle=Arthritis Rheumatol：缓释和速释非布索坦对痛风肾损害患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bcf14601ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720862, encodeId=f2f51e2086294, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet respir med：Tremelimumab（抗CTLA4单克隆抗体）联合durvalumab（抗PD-L1单克隆抗体）用于间皮瘤的疗效和安全性, objectType=article, longId=138186, objectId=481213818605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481213818605, replyNumber=0, likeNumber=64, createdTime=2019-03-25, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481213818605, moduleTitle=Lancet respir med：Tremelimumab（抗CTLA4单克隆抗体）联合durvalumab（抗PD-L1单克隆抗体）用于间皮瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481213818605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720861, encodeId=543b1e2086196, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性, objectType=article, longId=137013, objectId=ee2913e013e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2913e013e6, replyNumber=0, likeNumber=76, createdTime=2019-01-15, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2913e013e6, moduleTitle=Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2913e013e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720852, encodeId=7d5d1e20852d9, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）, objectType=article, longId=131097, objectId=815813109e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815813109e4e, replyNumber=0, likeNumber=62, createdTime=2018-04-14, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815813109e4e, moduleTitle=Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815813109e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720883, encodeId=5b7b1e20883c0, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Arthritis Rheumatol：ixekizumab对放射性轴性脊柱关节炎的疗效和安全性, objectType=article, longId=151941, objectId=f6a61519418d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6a61519418d, replyNumber=0, likeNumber=64, createdTime=2019-07-16, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6a61519418d, moduleTitle=Arthritis Rheumatol：ixekizumab对放射性轴性脊柱关节炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6a61519418d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720873, encodeId=1af31e20873f5, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Allergy：SQ屋尘螨舌下免疫治疗药片疗效和安全性研究, objectType=article, longId=147463, objectId=6bc014e4637e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bc014e4637e, replyNumber=0, likeNumber=71, createdTime=2019-07-23, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bc014e4637e, moduleTitle=Allergy：SQ屋尘螨舌下免疫治疗药片疗效和安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bc014e4637e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720854, encodeId=77d41e20854df, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性, objectType=article, longId=131784, objectId=6781131e84a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6781131e84a3, replyNumber=0, likeNumber=67, createdTime=2018-07-23, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6781131e84a3, moduleTitle=Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6781131e84a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720874, encodeId=1eae1e20874f9, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Gastroenterology：姜黄素在治疗家族性腺瘤性息肉病患者的疗效和安全性分析, objectType=article, longId=148848, objectId=f225148848cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f225148848cc, replyNumber=0, likeNumber=60, createdTime=2019-01-24, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f225148848cc, moduleTitle=Gastroenterology：姜黄素在治疗家族性腺瘤性息肉病患者的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f225148848cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效和安全性

2020-05-29

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet：一种吻合性胃旁路手术与Roux-en-Y胃旁路手术治疗肥胖(YOMEGA)的疗效和安全性:一项多中心、随机、开放标签、非劣效性试验

2019-10-07

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

张会来教授：替雷利珠单抗治疗复发/难治性经典型霍奇金淋巴瘤疗效和安全性均优，应用前景可期

2019-02-23

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Clin Med：Denosumab治疗骨质疏松症骨质疏松症的疗效和安全性

2019-10-23

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：Venetoclax联合地西他滨或阿扎胞苷用于AML老年患者的疗效和安全性

2019-06-20

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

坦度螺酮增效治疗高焦虑状态的抑郁症患者的疗效和安全性研究

2019-02-01

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet diabetes endo：磺脲类药物治疗KUNJ11突变导致的永久性新生儿糖尿病的长期疗效和安全性

2018-08-18

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Arthritis Rheumatol：ANCA相关性血管炎使用贝利木单抗和硫唑嘌呤维持缓解的疗效和安全性

2020-01-12

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Eur Heart J：阿司匹林对心血管事件一级预防的疗效和安全性分析

2019-07-11

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Diabetic Med：alirocumab在糖尿病前期患者和基线血糖正常患者中的疗效和安全性？

2018-05-10

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Liver Int：ombitasvir, paritaprevir/r+dasabuvir+ribavirin治疗HCV基因1b型肝硬化患者的真实疗效和安全性

2019-02-14

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Semin Arthritis Rheu：生物制剂在老年类风湿性关节炎患者中的疗效和安全性

2019-04-20

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

CheckMate-078研究：首次印证免疫治疗在中国人群的疗效和安全性

2019-05-20

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Arthritis Rheumatol：缓释和速释非布索坦对痛风肾损害患者的疗效和安全性

2019-04-30

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet respir med：Tremelimumab（抗CTLA4单克隆抗体）联合durvalumab（抗PD-L1单克隆抗体）用于间皮瘤的疗效和安全性

2019-03-25

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性

2019-01-15

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis： Sirukumab单药与阿达木单抗单药治疗活动性类风湿性关节炎的疗效和安全性比较（SIRROUND-H）

2018-04-14

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Arthritis Rheumatol：ixekizumab对放射性轴性脊柱关节炎的疗效和安全性

2019-07-16

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Allergy：SQ屋尘螨舌下免疫治疗药片疗效和安全性研究

2019-07-23

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性

2018-07-23

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Gastroenterology：姜黄素在治疗家族性腺瘤性息肉病患者的疗效和安全性分析

2019-01-24

科室
- - 订阅+
  - 更多科室
工具
服务